Mr. Damien McCallion:

My understanding is that targets are set by the Government and we also have targets within the programme. We are working towards that target as best we can, but it is very much led by supply. Supplies are constrained at the moment. As I mentioned previously, we are already experiencing a shortfall with AstraZeneca, which will limit the number of vaccines we can administer, the utilisation of our centres and our current plans. We are replanning again, and having just replanned last week, we are continuing to add changes to that.

In respect of the overall target, we are continuing to work towards that but there are significant supply challenges. The Deputy himself will be aware of such challenges over the past 14 days. As I mentioned, in the next four weeks alone, of the four vaccines of which we have supply, excepting Janssen which is currently off the table pending the EMA decision, 12 of the profiles have either changed in respect of volume or of dates, which affects delivery.

In terms of the overall target, we are continuing to work towards it, but there are very significant supply challenges. The Deputy will be aware of the challenges we have experienced in the last 14 days. As I mentioned, in the next four weeks alone, of the four vaccines of which we have supply, excepting Jansen which is currently off the table pending the EMA announcement, 12 of the delivery profiles have either changed in respect of volume or delivery dates, which affects delivery.